Search

everythinglearnresearchcommunity

for

Search:↓

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

Combining α1-blockers with 5α-reductase inhibitors improves urinary symptoms in men.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

Finasteride shows promise for treating hair loss and excessive hair growth, but more research is needed to confirm its effectiveness and safety.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

Finasteride is made through a series of chemical reactions starting from a specific intermediate compound.

5α-reductase inhibitors for hair loss can cause mild, reversible sexual side effects in some men.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

Men with hair loss who take a certain type of medication may experience fewer COVID-19 symptoms.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

Dutasteride and finasteride can change hair growth genes, helping treat hair loss.

Finasteride safely lowers DHT levels without affecting testosterone.

Oral and topical 5-alpha reductase inhibitors affect DHT levels and hair density differently in treating hair loss.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Combining dutasteride or finasteride with an α1 blocker is more effective for managing BPH than using either alone.

5-alpha reductase inhibitors help treat prostate issues in aging men, but their role in cancer prevention is debated.